Clinical Trials Browser

Phase 1 × INDUSTRY × Papillomavirus Infections × Clear all

Papillomavirus Infections

NCT06454175 2025-01-06

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Phase 1 Active not recruiting

72 enrolled

Condylomata Acuminata, Papillomavirus Infections

NCT03912831 2023-12-26

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Phase 1 Terminated

8 enrolled 13 charts

Neoplasms, Papillomavirus Infections

NCT04490512 2023-06-26

Study of FluBHPVE6E7 in HPV-16 Infected Women

Phase 1 Completed

28 enrolled

Papillomavirus Infections

NCT03900572 2023-04-13

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Phase 1 Completed

90 enrolled

Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Phase 1 Completed

160 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05672966 2023-01-06

Phase I Clinical Trial of a Candidate HPV Vaccine

Phase 1 Unknown

40 enrolled

Papillomavirus Infections

NCT04083196 2021-11-24

A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Phase 1 Completed

90 enrolled

Papillomavirus Infections

NCT03929172 2020-07-01

A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Phase 1 Completed

20 enrolled

Papillomavirus Infections

NCT03677960 2019-07-24

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Phase 1 Terminated

6 enrolled

GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT03202992 2019-02-07

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Phase 1 Completed

57 enrolled

GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT03085381 2018-09-14

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

Phase 1 Completed

90 enrolled

Papillomavirus Infections

NCT00541970 2018-08-17

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Phase 1 Completed

961 enrolled 43 charts

Gynecologic

Uterine Cervical Neoplasms, Virus Diseases, Papillomavirus Infections

NCT00549900 2018-07-20

A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females

Phase 1 Completed

30 enrolled 10 charts

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00685412 2017-09-13

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Phase 1 Completed

18 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00478621 2017-05-10

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

Phase 1 Completed

540 enrolled

Papillomavirus Infections

NCT00635830 2015-10-09

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

Phase 1 Completed

40 enrolled 7 charts

Papillomavirus Infections

Clinical Trials

Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Study of FluBHPVE6E7 in HPV-16 Infected Women

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Phase I Clinical Trial of a Candidate HPV Vaccine

A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)